Extracorporeal magnetic innervation therapy for stress urinary incontinence

Galloway, Niall T.M.; El-Galley, Rizk; Sand, Peter K.; Appell, Rodney A.; Russell, Howard W.; Carlan, S. J.

doi:10.1016/s0090-4295(99)00037-0

Cited by 127 publications

(129 citation statements)

References 4 publications

Supporting

Mentioning

126

Contrasting

Unclassified

Order By: Relevance

“…This allows all the tissues of the perineum to be penetrated by the therapeutic magnetic field flux. 14 Treatment sessions were for 20 min, twice a week for 6 weeks. The frequency of the pulse field was 10 Hz, intermittently for 10 min, followed by a rest period of 2 min, and a second treatment at 50 Hz intermittently for 10 min.…”

Section: Methods Of Treatmentmentioning

confidence: 99%

More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study

Paick

2006

Prostate Cancer Prostatic Dis

View full text Add to dashboard Cite

The objective of this study was to evaluate whether extracorporeal magnetic innervation (ExMI) combined with a-blocker therapy is more effective than a-blocker monotherapy for patients with non-inflammatory chronic prostatitis (CP)/chronic pelvic pain syndrome (CPPS), category IIIB. Patients were randomized to either terazosin monotherapy (group 1, n ¼ 21) or terazosin combined with ExMI therapy (group 2, n ¼ 19). Patients in group 2 had 12 treatment sessions of ExMI twice a week during 6 weeks. None of the patients experienced any side effects from treatment. The changes in each domain of the National Institutes of Health (NIH)-Chronic Prostatitis Symptom Index (CPSI) measured on week 6 were not significantly different between the groups. However, the difference (median, 25-75th percentiles) between the two groups in total NIH-CPSI scores was À4 (À11.5, À2) for group 1 and À12 (À17.3, À2.3) for group 2, respectively (P ¼ 0.047). At 6 weeks, 47.6% (10 of 21) of group 1 had a 425% decrease in total NIH-CPSI compared with 78.9% (15 of 19) of group 2 (P ¼ 0.041). Also, more patients in group 2 (78.9%) were rated as responders with a 6-point decrease in NIH-CPSI compared with group 1 (47.6%) (P ¼ 0.041). The early results suggest that ExMI combined with a-blocker therapy has better effect than a-blocker monotherapy for the treatment of CP/CPPS.

show abstract

Section: Methods Of Treatmentmentioning

confidence: 99%

More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study

Paick

2006

Prostate Cancer Prostatic Dis

View full text Add to dashboard Cite

show abstract

“…[24], для лечения СНМ у женщин -экстракорпоральной МС (ЭМС) области тазового дна. Данная технология, равно как и термин, возникли в противоположность уже используемой и показавшей свою эффективность ЭС с применени-ем вагинальных и ректальных электродов.…”

Section: том 7 Volunclassified

Peripheral repetitive magnetic stimulation for the treatment of neurogenic urinary disorders: literature review and investigational study

Borodulina¹,

Rachin²,

Бадалов³

et al. 2017

Neuromuscular Diseases

View full text Add to dashboard Cite

ТОМ 7 VOL. 7Нервно-мышечные Б О Л Е З Н И Neuromuscular DISEASES 54 Оригинальные исследованияВведение Возможности терапевтического применения энер-гии магнитного поля -предмет практического инте-реса на протяжении нескольких столетий. Начало этому пути положили эксперименты Л. Гальвани, ко-торый в XVIII веке сформулировал теорию животного электричества и создал базу для развития электрофи-зиологии. С этого времени началось более глубокое изучение электромагнитного взаимодействия. Откры-тие явления электромагнитной индукции М. Фараде-ем в середине XIX века позволило установить, что в от-вет на переменное магнитное поле (ПМП) в проводящей среде возникает электрический ток. На этом постулате физики в последующем базировал-ся механизм воздействия магнитного импульса на жи-вую ткань. В противоположность электрической сти-муляции

show abstract

“…The roots of sacral nerves S2-S4 provide the primary autonomic and somatic innervations of the urinary tract, including pelvic floor, urethra, bladder and other pelvic organs, and stimulation of these roots is an efficient way to modulate the pelvic floor and control functions of pelvic organs (Shafik, 2000). Magnetic stimulation can be applied both at the sacral root (Sheriff et al, 1996;Fujishiro et al, 2002) and the peri-anal region Galloway et al, 1999). However, the commercially available stimulator is usually a chair type and stimulates the peri-anal region including pelvic floor muscles because of difficulty to fix the coil to the sacral root for a long time.…”

Section: Basic Principles/mechanismsmentioning

confidence: 99%

Neuromodulation in Management of Overactive Bladder

Oh-oka¹

2012

Topics in Neuromodulation Treatment

View full text Add to dashboard Cite

Extracorporeal magnetic innervation therapy for stress urinary incontinence

Cited by 127 publications

References 4 publications

More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study

More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study

Peripheral repetitive magnetic stimulation for the treatment of neurogenic urinary disorders: literature review and investigational study

Neuromodulation in Management of Overactive Bladder

Contact Info

Product

Resources

About